A Big Pharma Update on Fighting Superbugs: GSK Report Industry Developments in Addressing AMR
Summary
London, United Kingdom, January 12, 2017 --( A recent report by Public Health England revealed that fewer antibiotics are being prescribed by GPs and clinicians for the first time.* Source: http://bit.ly/2fx6MtL The GSK keynote address will delve further into key topics surrounding partnerships with healthcare systems to ensure sterile manufacturing, antibiotic stewardship and new economic models for sustainable solutions.He will be joined in London this March by a notable speaker line up including: · Sumathi Nambiar, Director, Division of Anti-Infective Products, FDA · Richard Bax, Senior Partner, TranScrip · Lloyd Czaplewski, Director, Chemical Biology Ventures · Chris Houchens, Branch Chief, BARDA · Aileen Rubio, Head of Biology, Spero Therapeutics · David Williams, Chief Executive Officer, Discuva · Martin Everett, Chief Scientific Officer, ANTABIO SAS · Jean de Gunzburg, Scientific Director, Da Volterra · William J Weiss, Director, Pre-Clinical Services, UNT System College of Pharmacy · Xavier Duportet, CEO, Eligo Bioscience Further details including a detailed conference agenda and full speaker line-up is available at www.superbugssuperdrugs.com Superbugs & Superdrugs 2017 20th & 21st March Copthorne Tara Hotel, London, UK http://www.superbugssuperdrugs.com Contact Information: For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk For delegate enquires contact Fateja Begum on Tel: +44 (0)20 7827 6184 / Email: fbegum@smi-online.co.uk For exhibition and sponsorship enquires contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities.London, United Kingdom, January 12, 2017 --( PR.com )-- SMi Group will welcome the expertise of James Anderson, Head of Corporate Affairs from GlaxoSmithKline, who will be providing attendees at the 19th annual Superbugs and Superdrugs show with an exclusive update on how the pharmaceutical industry is helping address anti-microbial resistance (AMR).A recent report by Public Health England revealed that fewer antibiotics are being prescribed by GPs and clinicians for the first time.* Source: http://bit.ly/2fx6MtLThe GSK keynote address will delve further into key topics surrounding partnerships with healthcare systems to ensure sterile manufacturing, antibiotic stewardship and new economic models for sustainable solutions.He will be joined in London this March by a notable speaker line up including:· Sumathi Nambiar, Director, Division of Anti-Infective Products, FDA· Richard Bax, Senior Partner, TranScrip· Lloyd Czaplewski, Director, Chemical Biology Ventures· Chris Houchens, Branch Chief, BARDA· Aileen Rubio, Head of Biology, Spero Therapeutics· David Williams, Chief Executive Officer, Discuva· Martin Everett, Chief Scientific Officer, ANTABIO SAS· Jean de Gunzburg, Scientific Director, Da Volterra· William J Weiss, Director, Pre-Clinical Services, UNT System College of Pharmacy· Xavier Duportet, CEO, Eligo BioscienceFurther details including a detailed conference agenda and full speaker line-up is available at www.superbugssuperdrugs.comSuperbugs & Superdrugs 201720th & 21st MarchCopthorne Tara Hotel, London, UKhttp://www.superbugssuperdrugs.comContact Information:For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.ukFor delegate enquires contact Fateja Begum on Tel: +44 (0)20 7827 6184 / Email: fbegum@smi-online.co.ukFor exhibition and sponsorship enquires contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.ukAbout SMi Group:Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities.